SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-273522
Filing Date
2023-11-08
Accepted
2023-11-08 16:11:06
Documents
12
Period of Report
2023-11-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d594283d8k.htm   iXBRL 8-K 40987
  Complete submission text file 0001193125-23-273522.txt   169559

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acer-20231108.xsd EX-101.SCH 2505
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20231108_lab.xml EX-101.LAB 18709
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20231108_pre.xml EX-101.PRE 11683
6 EXTRACTED XBRL INSTANCE DOCUMENT d594283d8k_htm.xml XML 3868
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 231387945
SIC: 2834 Pharmaceutical Preparations